https://portalresearch.org/portal_work/risk-responsibility-and-generic-drugs/ 2026-03-16T19:39:56+00:00 https://portalresearch.org/portal_work/reputation-and-precedent-in-the-bevacizumab-decision/ 2026-03-16T19:39:56+00:00 https://portalresearch.org/portal_work/the-supreme-court-process-patents-and-medical-innovation/ 2026-03-16T19:39:57+00:00 https://portalresearch.org/portal_work/the-fda-amendments-act-of-2007-assessing-its-effects-a-decade-later/ 2026-03-16T19:39:57+00:00 https://portalresearch.org/portal_work/improving-the-use-of-fda-advisory-committees/ 2026-03-16T19:39:57+00:00 https://portalresearch.org/portal_work/evaluation-of-aducanumab-for-alzheimer-disease-scientific-evidence-and-regulatory-review-involving-efficacy-safety-and-futility/ 2026-03-16T19:39:57+00:00 https://portalresearch.org/portal_work/extending-drug-monopolies-by-patenting-safe-drug-use/ 2026-03-16T19:39:57+00:00 https://portalresearch.org/portal_work/legal-liability-of-generic-vs-brand-drug-manufacturers-for-inadequate-product-labels/ 2026-03-16T19:39:57+00:00 https://portalresearch.org/portal_work/new-drug-approvals-in-oncology/ 2026-03-16T19:39:57+00:00 https://portalresearch.org/portal_work/pain-management-and-opioid-regulation-continuing-public-health-challenges/ 2026-03-16T19:39:57+00:00 https://portalresearch.org/portal_work/low-dose-desmopressin-nasal-spray-and-fda-approval-reply/ 2026-03-16T19:39:57+00:00 https://portalresearch.org/portal_work/public-funding-and-the-importance-of-reasonable-pricing-for-buprenorphine/ 2026-03-16T19:39:57+00:00 https://portalresearch.org/portal_work/the-medical-device-excise-tax-over-before-it-begins-reply/ 2026-03-16T19:39:57+00:00 https://portalresearch.org/portal_work/the-21st-century-cures-act-will-it-take-us-back-in-time-reply/ 2026-03-16T19:39:57+00:00 https://portalresearch.org/portal_work/regulation-of-drugs-for-early-alzheimers-disease/ 2026-03-16T19:39:57+00:00 https://portalresearch.org/portal_work/recent-trends-in-prescription-drug-launch-prices-reply/ 2026-03-16T19:39:57+00:00 https://portalresearch.org/portal_work/physician-trainees-interactions-with-the-pharmaceutical-industry-reply/ 2026-03-16T19:39:57+00:00 https://portalresearch.org/portal_work/qalys-in-health-resource-usage-decisions-reply/ 2026-03-16T19:39:57+00:00 https://portalresearch.org/portal_work/antibiotic-development-incentives-that-reflect-societal-value-of-antibiotics-reply/ 2026-03-16T19:39:57+00:00 https://portalresearch.org/portal_work/is-the-concept-of-clinical-equipoise-still-relevant-to-research/ 2026-03-16T19:39:57+00:00 https://portalresearch.org/portal_work/prioritization-of-generic-drug-review-reply/ 2026-03-16T19:39:57+00:00 https://portalresearch.org/portal_work/factors-influencing-prescription-drug-costs-in-the-united-states-reply/ 2026-03-16T19:39:57+00:00 https://portalresearch.org/portal_work/prescription-trends-brand-name-drugs-vs-generic-reply/ 2026-03-16T19:39:59+00:00 https://portalresearch.org/portal_work/insulin-patents-and-market-exclusivities-unresolved-issues-reply/ 2026-03-16T19:39:59+00:00 https://portalresearch.org/portal_work/information-transparency-in-the-drug-approval-process-reply/ 2026-03-16T19:39:59+00:00 https://portalresearch.org/portal_work/high-cost-generic-drugs-implications-for-patients-and-policymakers-reply/ 2026-03-16T19:39:59+00:00 https://portalresearch.org/portal_work/burden-of-changes-in-generic-pill-appearance-reply/ 2026-03-16T19:39:59+00:00 https://portalresearch.org/portal_work/new-fda-breakthrough-drug-category-implications-for-patients-reply/ 2026-03-16T19:39:59+00:00 https://portalresearch.org/portal_work/over-the-counter-availability-of-rescue-inhalers-for-asthma-reply/ 2026-03-16T19:39:59+00:00 https://portalresearch.org/portal_work/substitution-of-generic-drugs-and-biosimilars-reply/ 2026-03-16T19:39:59+00:00 https://portalresearch.org/portal_work/efficacy-of-the-priority-review-voucher-program-reply/ 2026-03-16T19:39:59+00:00 https://portalresearch.org/portal_work/the-fight-against-multidrug-resistant-bacteria-reply/ 2026-03-16T19:39:59+00:00 https://portalresearch.org/portal_work/delayed-generic-market-saturation-after-patent-expiration-a-billion-dollar-problem/ 2026-03-16T19:39:59+00:00 https://portalresearch.org/portal_work/institutionalizing-misinformation-the-dietary-supplement-listing-act-of-2022/ 2026-03-16T19:39:59+00:00 https://portalresearch.org/portal_work/recalibrating-privacy-protections-to-promote-patient-engagement/ 2026-03-16T19:39:59+00:00 https://portalresearch.org/portal_work/high-cost-generic-drugs-implications-for-patients-and-policymakers/ 2026-03-16T19:39:59+00:00 https://portalresearch.org/portal_work/the-tax-cuts-and-jobs-act-of-2017-and-the-pharmaceutical-industry/ 2026-03-16T19:39:59+00:00 https://portalresearch.org/portal_work/target-small-firms-for-antibiotic-innovation/ 2026-03-16T19:39:59+00:00 https://portalresearch.org/portal_work/challenges-in-the-development-of-novel-cardiovascular-therapies/ 2026-03-16T19:39:59+00:00 https://portalresearch.org/portal_work/experiences-with-and-challenges-afforded-by-expedited-regulatory-pathways/ 2026-03-16T19:39:59+00:00 https://portalresearch.org/portal_work/revisiting-the-national-institutes-of-health-fair-pricing-condition-promoting-the-affordability-of-drugs-developed-with-government-support/ 2026-03-16T19:39:59+00:00 https://portalresearch.org/portal_work/reprioritizing-research-activity-for-the-post%e2%80%90antibiotic-era-ethical-legal-and-social-considerations/ 2026-03-16T19:39:59+00:00 https://portalresearch.org/portal_work/op-ed-healing-the-overwhelmed-physician/ 2026-03-16T21:32:19+00:00 https://portalresearch.org/portal_work/op-ed-prices-for-new-drugs-are-rising-20-percent-a-year-congress-needs-to-act/ 2026-03-16T21:32:19+00:00 https://portalresearch.org/portal_work/op-ed-the-fda-has-reached-a-new-low/ 2026-03-16T21:32:19+00:00 https://portalresearch.org/portal_work/op-ed-what-trump-should-actually-do-about-the-high-cost-of-drugs/ 2026-03-16T21:32:19+00:00 https://portalresearch.org/portal_work/op-ed-increase-transparency-at-the-fda-we-need-sunlight-to-fight-the-pandemic/ 2026-03-16T21:32:19+00:00 https://portalresearch.org/portal_work/op-ed-do-large-pharma-companies-provide-drug-development-innovation-our-analysis-says-no/ 2026-03-16T21:32:19+00:00 https://portalresearch.org/portal_work/op-ed-searching-for-an-effective-covid-19-treatment-promise-and-peril/ 2026-03-16T21:32:19+00:00 https://portalresearch.org/portal_work/op-ed-prevent-a-legal-catch-22-that-could-push-thousands-of-generic-drugs-off-the-market/ 2026-03-16T21:32:19+00:00 https://portalresearch.org/portal_work/op-ed-makena-is-just-the-latest-in-accelerated-approval-mayhem/ 2026-03-16T21:32:19+00:00 https://portalresearch.org/portal_work/op-ed-letting-the-government-negotiate-drug-prices-wont-hurt-innovation/ 2026-03-16T21:32:19+00:00 https://portalresearch.org/portal_work/op-ed-biden-can-lower-drug-prices-without-congress-doing-anything/ 2026-03-16T21:32:19+00:00 https://portalresearch.org/portal_work/op-ed-a-simple-way-for-the-government-to-curb-inflated-drug-prices/ 2026-03-16T21:32:19+00:00 https://portalresearch.org/portal_work/op-ed-medicare-could-have-saved-3-billion-buying-drugs-the-mark-cuban-way/ 2026-03-16T21:32:19+00:00 https://portalresearch.org/portal_work/op-ed-three-things-trump-can-do-to-bring-drug-prices-way-down/ 2026-03-16T21:32:19+00:00 https://portalresearch.org/portal_work/lifecycle-regulation-and-evaluation-of-artificial-intelligence-and-machine-learning-based-medical-devices/ 2026-03-16T21:32:19+00:00 https://portalresearch.org/portal_work/op-ed-superbugs-call-for-super-changes-in-drug-sale-rules/ 2026-03-16T21:32:19+00:00 https://portalresearch.org/portal_work/op-ed-dont-limit-the-powers-of-the-fda/ 2026-03-16T21:32:19+00:00 https://portalresearch.org/portal_work/op-ed-drugs-should-be-labelled-to-say-how-well-they-work/ 2026-03-16T21:32:19+00:00 https://portalresearch.org/portal_work/op-ed-get-generic-drugs-to-market-faster/ 2026-03-16T21:32:19+00:00 https://portalresearch.org/portal_work/inflation-reduction-act-and-us-drug-pricing/ 2026-03-16T21:32:19+00:00 https://portalresearch.org/portal_work/pharmacy-benefit-managers-practices-controversies-and-what-lies-ahead/ 2026-03-16T21:32:20+00:00 https://portalresearch.org/portal_work/accumulators-and-maximizers-a-new-front-in-the-battle-over-drug-costs-part-1/ 2026-03-16T21:32:20+00:00 https://portalresearch.org/portal_work/accumulators-and-maximizers-a-new-front-in-the-battle-over-drug-costs-part-2/ 2026-03-16T21:32:20+00:00 https://portalresearch.org/portal_work/policy-options-for-increasing-generic-drug-competition-through-importation/ 2026-03-16T21:32:20+00:00 https://portalresearch.org/portal_work/taxing-drug-price-spikes-assessing-the-potential-impact/ 2026-03-16T21:32:20+00:00 https://portalresearch.org/portal_work/prescription-drug-regulation-promotion-and-advocacy-has-gotten-more-vexing-in-2017/ 2026-03-16T21:32:20+00:00 https://portalresearch.org/portal_work/the-role-of-black-box-warnings-in-safe-prescribing-practices/ 2026-03-16T21:32:20+00:00 https://portalresearch.org/portal_work/ensuring-timely-approval-of-generic-drugs/ 2026-03-16T21:32:20+00:00 https://portalresearch.org/portal_work/the-short-term-and-long-term-outlook-of-drug-coupons/ 2026-03-16T21:32:20+00:00 https://portalresearch.org/portal_work/the-future-of-precision-medicine-great-promise-significant-challenges/ 2026-03-16T21:32:20+00:00 https://portalresearch.org/portal_work/to-spur-medical-innovation-make-corporate-cheaters-pay/ 2026-03-16T21:32:20+00:00 https://portalresearch.org/portal_work/expanding-coercive-treatment-is-the-wrong-solution-for-the-opioid-crisis/ 2026-03-16T21:32:20+00:00 https://portalresearch.org/portal_work/what-do-high-drug-prices-buy-us/ 2026-03-16T21:32:20+00:00 https://portalresearch.org/portal_work/president-biden-already-has-the-covid-vaccine-recipe-he-should-share-it/ 2026-03-16T21:32:20+00:00 https://portalresearch.org/portal_work/biosimilar-approvals-and-the-bpcia-too-soon-to-give-up/ 2026-03-16T21:32:20+00:00 https://portalresearch.org/portal_work/drugs-dont-work-if-people-cant-afford-them-the-high-price-of-tisagenlecleucel/ 2026-03-16T21:32:20+00:00 https://portalresearch.org/portal_work/challenging-patents-to-promote-timely-generic-drug-entry-the-second-look-act-and-other-options/ 2026-03-16T21:32:20+00:00 https://portalresearch.org/portal_work/why-government-patent-use-to-lower-drug-costs-wont-stifle-innovation/ 2026-03-16T21:32:20+00:00 https://portalresearch.org/portal_work/addressing-generic-drug-unaffordability-and-shortages-by-globalizing-the-market-for-old-drugs/ 2026-03-16T21:32:20+00:00 https://portalresearch.org/portal_work/to-incentivize-covid-19-vaccination-give-vaccinated-individuals-a-discount-on-their-insurance-premiums/ 2026-03-16T21:32:22+00:00 https://portalresearch.org/portal_work/march-in-rights-and-compulsory-licensing-safety-nets-for-access-to-a-covid-19-vaccine/ 2026-03-16T21:32:22+00:00 https://portalresearch.org/portal_work/the-first-amendment-and-pharmaceutical-promotion/ 2026-03-16T21:32:22+00:00 https://portalresearch.org/portal_work/the-current-21st-century-cures-legislation-is-still-a-bad-deal-for-patients/ 2026-03-16T21:32:22+00:00 https://portalresearch.org/portal_work/the-daraprim-price-hike-and-a-role-for-antitrust/ 2026-03-16T21:32:22+00:00 https://portalresearch.org/portal_work/reference-check-a-simple-strategy-to-improve-drug-patent-quality/ 2026-03-16T21:32:22+00:00 https://portalresearch.org/portal_work/four-ways-to-address-the-ethical-tensions-around-expedited-approval-of-new-prescription-drugs/ 2026-03-16T21:32:22+00:00 https://portalresearch.org/portal_work/new-drug-and-device-approval-what-is-sufficient-evidence/ 2026-03-16T21:32:22+00:00 https://portalresearch.org/portal_work/accelerating-medicines-partnership-a-new-public-private-collaboration-for-drug-discovery/ 2026-03-16T21:32:22+00:00 https://portalresearch.org/portal_work/nearly-one-third-of-new-drugs-are-no-better-than-older-drugs-and-some-are-worse/ 2026-03-16T21:32:22+00:00 https://portalresearch.org/portal_work/assessing-the-legality-of-mandates-for-vaccines-authorized-via-an-emergency-use-authorization/ 2026-03-16T21:32:22+00:00 https://portalresearch.org/portal_work/ftc-v-actavis-the-supreme-court-issues-a-reversal-on-reverse-payments/ 2026-03-16T21:48:30+00:00 https://portalresearch.org/portal_work/biosimilar-interchangeability-and-substitution-in-the-us-what-comes-next/ 2026-03-17T14:19:31+00:00 https://portalresearch.org/portal_work/a-court-decision-on-skinny-labeling-another-challenge-for-less-expensive-drugs/ 2026-03-17T14:49:33+00:00 https://portalresearch.org/portal_work/share-of-sales-subject-to-medicare-inflation-rebates-and-price-increases-of-top%e2%80%90selling-drugs/ 2026-03-17T14:50:38+00:00 https://portalresearch.org/portal_work/data-sharing-that-enables-postapproval-drug-and-device-research-and-protects-patient-privacy-best-practice-recommendations/ 2026-03-17T14:56:23+00:00 https://portalresearch.org/portal_work/potential-roadblocks-in-healthcare-big-data-collection-gobeille-v-liberty-mutual-erisa-and-all-payer-claims-databases/ 2026-03-17T14:56:23+00:00 https://portalresearch.org/portal_work/innovation-and-the-orphan-drug-act-1983-2009-regulatory-and-clinical-characteristics-of-approved-orphan-drugs/ 2026-03-17T14:56:23+00:00 https://portalresearch.org/portal_work/ensuring-patient-safety-and-benefit-in-use-of-medical-devices-granted-expedited-approval/ 2026-03-17T14:56:23+00:00 https://portalresearch.org/portal_work/preventing-medical-device-borne-outbreaks-the-case-of-high-level-disinfection-policy-for-duodenoscopes/ 2026-03-17T14:56:23+00:00 https://portalresearch.org/portal_work/comments-on-draft-interagency-guidance-framework-for-considering-the-exercise-of-march-in-rights/ 2026-03-17T18:12:13+00:00 https://portalresearch.org/portal_work/comments-for-hearing-administering-the-hatch-waxman-amendments-ensuring-an-appropriate-balance-between-innovation-and-access-luo/ 2026-03-17T18:12:13+00:00 https://portalresearch.org/portal_work/comments-for-hearing-the-future-of-insulin-biosimilars-increasing-access-and-facilitating-the-efficient-development-of-biosimilar-and-interchangeable-insulin-products/ 2026-03-17T18:12:13+00:00 https://portalresearch.org/portal_work/comments-for-listening-session-optimizing-fdas-use-of-and-processes-for-advisory-committees/ 2026-03-17T18:12:13+00:00 https://portalresearch.org/portal_work/comments-on-draft-guidance-expedited-program-for-serious-condions-accelerated-approval-of-drugs-and-biologics/ 2026-03-17T18:12:13+00:00 https://portalresearch.org/portal_work/comments-on-proposed-rule-discrimination-on-the-basis-of-disability-in-health-and-human-services-programs-or-activities/ 2026-03-17T18:12:13+00:00 https://portalresearch.org/portal_work/additional-comments-on-proposed-rule-supplemental-applications-proposing-labeling-changes-for-approved-drugs-and-biological-products/ 2026-03-17T18:12:13+00:00 https://portalresearch.org/portal_work/comments-on-proposed-rule-medicare-program-revisions-to-payment-policies-under-the-physician-fee-schedule-and-other-revisions-to-part-b-for-cy2016/ 2026-03-17T18:12:13+00:00 https://portalresearch.org/portal_work/comments-on-proposed-criteria-for-first-generic-submissions-for-purposes-of-anda-review-prioritization-under-gdufa/ 2026-03-17T18:12:13+00:00 https://portalresearch.org/portal_work/comments-on-implementation-of-executive-order-13937-executive-order-on-access-to-affordable-life-saving-medications/ 2026-03-17T18:12:13+00:00 https://portalresearch.org/portal_work/comments-for-joint-meeting-of-the-anesthetic-and-analgesic-drug-products-advisory-committee-and-the-drug-safety-and-risk-management-advisory-committee/ 2026-03-17T18:12:13+00:00 https://portalresearch.org/portal_work/comments-on-draft-guidance-opioid-analgesic-drugs-considerations-for-benefit-risk-assessment-framework/ 2026-03-17T18:12:13+00:00 https://portalresearch.org/portal_work/comments-for-hearing-standards-for-future-opioid-analgesic-approvals-and-incentives-for-new-therapeutics-to-treat-pain-and-addiction/ 2026-03-17T18:12:13+00:00 https://portalresearch.org/portal_work/comments-on-notice-uspto-initiatives-to-ensure-the-robustness-and-reliability-of-patent-rights/ 2026-03-17T18:12:13+00:00 https://portalresearch.org/portal_work/comments-to-the-fda-transparency-task-force/ 2026-03-17T18:12:13+00:00 https://portalresearch.org/portal_work/comments-on-notice-new-drugs-regulatory-program-modernization-improving-approval-package-documentation-and-communication-doshi-et-al/ 2026-03-17T18:12:13+00:00 https://portalresearch.org/portal_work/comments-on-draft-guidance-clinical-trial-considerations-to-support-accelerated-approval-of-oncology-therapeutics/ 2026-03-17T18:12:13+00:00 https://portalresearch.org/portal_work/comments-on-notice-new-drugs-regulatory-program-modernization-improving-approval-package-documentation-and-communication-herder-et-al/ 2026-03-17T18:12:13+00:00 https://portalresearch.org/portal_work/comments-on-proposed-rule-supplemental-applications-proposing-labeling-changes-for-approved-drugs-and-biological-products/ 2026-03-17T18:12:13+00:00 https://portalresearch.org/portal_work/comments-on-draft-guidance-size-shape-and-other-physical-attributes-of-generic-tablets-and-capsules/ 2026-03-17T18:12:13+00:00 https://portalresearch.org/portal_work/comments-for-hearing-administering-the-hatch-waxman-amendments-ensuring-an-appropriate-balance-between-innovation-and-access-sarpatwari-et-al/ 2026-03-17T18:12:15+00:00 https://portalresearch.org/portal_work/comments-for-hearing-administering-the-hatch-waxman-amendments-ensuring-an-appropriate-balance-between-innovation-and-access-sarpatwari-sinha-kesselheim/ 2026-03-17T18:12:15+00:00 https://portalresearch.org/portal_work/comments-on-proposed-rule-rights-to-federally-funded-inventions-and-licensing-of-government-owned-inventions/ 2026-03-17T18:12:15+00:00 https://portalresearch.org/portal_work/comments-for-public-workshop-generic-drug-user-fee-amendments-of-2012-regulatory-science-initiatives-part-15/ 2026-03-17T18:12:15+00:00 https://portalresearch.org/portal_work/comments-on-draft-guidance-expedited-program-for-serious-conditions-accelerated-approval-of-drugs-and-biologics/ 2026-03-17T18:12:15+00:00 https://portalresearch.org/portal_work/comments-on-draft-guidance-accelerated-approval-and-considerations-for-determining-whether-a-confirmatory-trial-is-underway/ 2026-03-17T18:12:15+00:00 https://portalresearch.org/portal_work/comments-for-listening-session-joint-uspto-fda-collaboration-initiatives-tu/ 2026-03-17T18:12:15+00:00 https://portalresearch.org/portal_work/comments-on-proposed-rule-terminal-disclaimer-practice-to-obviate-nonstatutory-double-patenting/ 2026-03-17T18:12:15+00:00 https://portalresearch.org/portal_work/comments-for-listening-session-joint-uspto-fda-collaboration-initiatives-van-de-wiele/ 2026-03-17T18:12:15+00:00 https://portalresearch.org/portal_work/pharmaceutical-policy-in-the-united-states-in-2019-an-overview-of-the-landscape-and-avenues-for-improvement/ 2026-03-17T20:04:44+00:00 https://portalresearch.org/portal_work/transparency-on-prescription-drug-research-expenditures-a-lever-for-restraining-pricing/ 2026-03-26T21:26:41+00:00 https://portalresearch.org/portal_work/patent-law-and-policy/ 2026-03-26T21:26:41+00:00 https://portalresearch.org/portal_work/patient-perceptions-of-and-experiences-with-risk-evaluation-and-mitigation-strategies/ 2026-04-08T16:11:46+00:00 https://portalresearch.org/portal_work/the-25th-anniversary-of-a-nearly-unknown-health-policy-turning-point-2/ 2026-04-08T16:12:33+00:00 https://portalresearch.org/portal_work/the-curious-constraints-on-clofazimine-2/ 2026-04-08T16:16:10+00:00 https://portalresearch.org/portal_work/generic-liraglutide-overlooked-but-not-forgotten-2/ 2026-04-08T16:17:23+00:00 https://portalresearch.org/portal_work/global-access-to-commercial-car-t-cells-a-cross-sectional-study-of-health-technology-assessment-in-the-g20/ 2026-04-08T16:21:41+00:00 https://portalresearch.org/portal_work/physician-antibiotic-prescribing-preferences-in-community-acquired-pneumonia-and-complicated-urinary-tract-infections-a-national-discrete-choice-experiment/ 2026-04-08T16:23:18+00:00 https://portalresearch.org/portal_work/improving-competition-to-lower-us-prescription-drug-costs/ 2026-04-08T17:04:47+00:00 https://portalresearch.org/portal_work/litigating-authority-for-the-fda/ 2026-04-08T17:04:47+00:00 https://portalresearch.org/portal_work/using-prescription-medication-utilization-trends-to-evaluate-health-system-resilience-and-inform-future-emergency-preparedness/ 2026-04-08T17:04:47+00:00 https://portalresearch.org/portal_work/the-growing-success-of-medicare-drug-price-negotiation/ 2026-04-08T17:04:47+00:00 https://portalresearch.org/portal_work/risk-of-neutropenia-related-hospitalisation-among-clozapine-initiators/ 2026-04-08T17:04:47+00:00 https://portalresearch.org/portal_work/ensuring-integrity-of-the-medicaid-drug-rebate-program/ 2026-04-08T17:04:47+00:00 https://portalresearch.org/portal_work/law-politics-and-expert-panels-at-the-us-food-and-drug-administration/ 2026-04-08T17:04:47+00:00 https://portalresearch.org/portal_work/new-medicare-payment-policy-on-drug-shortages/ 2026-04-08T17:04:47+00:00 https://portalresearch.org/portal_work/the-case-against-six-month-limits-on-buprenorphine-telehealth-prescribing/ 2026-04-08T17:04:47+00:00 https://portalresearch.org/portal_work/clinical-benefit-and-the-trump-administrations-cancer-medicine-reforms/ 2026-04-08T17:04:47+00:00 https://portalresearch.org/portal_work/list-price-reductions-among-brand-name-ics-laba-inhalers-in-2024-were-associated-with-increased-generic-uptake/ 2026-04-08T17:04:47+00:00 https://portalresearch.org/portal_work/scope-and-characteristics-of-patients-filling-medications-through-specialty-pharmacies-by-ownership-type/ 2026-04-08T17:04:47+00:00 https://portalresearch.org/portal_work/bundling-drugs-the-risks-of-combining-copay-assistance/ 2026-04-08T17:04:47+00:00 https://portalresearch.org/portal_work/cost-related-medication-nonadherence-after-the-inflation-reduction-act/ 2026-04-08T17:04:47+00:00 https://portalresearch.org/portal_work/fluticasone-vs-budesonide-based-dual-therapy-for-copd/ 2026-04-08T17:04:47+00:00 https://portalresearch.org/portal_work/relevant-industry-payments-to-2023-2024-voting-members-of-the-advisory-committee-on-immunization-practices/ 2026-04-08T17:04:47+00:00 https://portalresearch.org/portal_work/national-prescribing-trends-of-direct-acting-antivirals-for-hepatitis-c/ 2026-04-08T17:04:47+00:00 https://portalresearch.org/portal_work/brand-manufacturer-coupons-and-pharmaceutical-product-hopping/ 2026-04-08T17:04:47+00:00 https://portalresearch.org/portal_work/inflation-reduction-act-changes-to-part-d-plan-design-lower-premiums-higher-deductibles-and-some-smaller-formularies/ 2026-04-08T17:04:49+00:00 https://portalresearch.org/portal_work/testimony-in-support-of-prescription-drug-price-transparency-and-disclosure-legislation-sb-925/ 2026-04-08T22:29:45+00:00 https://portalresearch.org/portal_work/testimony-in-support-of-prescription-drug-price-transparency-and-disclosure-legislation-sb-445/ 2026-04-08T22:30:12+00:00 https://portalresearch.org/portal_work/testimony-under-the-influence-can-we-provide-doctors-an-alternative-to-biased-drug-reviews/ 2026-04-08T23:26:53+00:00 https://portalresearch.org/portal_work/testimony-why-are-some-generic-drugs-skyrocketing-in-price/ 2026-04-08T23:26:53+00:00 https://portalresearch.org/portal_work/testimony-on-the-impact-of-s-1048-a-bill-to-improve-transparency-of-drug-research-and-development-costs/ 2026-04-08T23:26:53+00:00 https://portalresearch.org/portal_work/testimony-in-support-of-legislation-on-pharmaceutical-transparency-and-price-gouging/ 2026-04-08T23:26:53+00:00 https://portalresearch.org/portal_work/testimony-on-the-impact-of-s-706-h-1333-an-act-to-ensure-prescription-drug-cost-transparency-and-affordability/ 2026-04-08T23:26:53+00:00 https://portalresearch.org/portal_work/testimony-high-drug-prices-in-the-us-what-we-can-learn-from-other-countries-and-some-us-states/ 2026-04-08T23:26:53+00:00 https://portalresearch.org/portal_work/testimony-taxpayers-paid-billions-for-it-so-why-would-moderna-consider-quadrupling-the-price-of-the-covid-vaccine/ 2026-04-08T23:26:53+00:00 https://portalresearch.org/portal_work/testimony-in-support-of-s-749-an-act-relative-to-pharmaceutical-access-costs-and-transparency/ 2026-04-08T23:26:53+00:00 https://portalresearch.org/portal_work/testimony-patent-thickets-and-product-hops-how-congress-could-reward-legitimate-innovation-while-facilitating-more-timely-generic-competition/ 2026-04-08T23:26:53+00:00 https://portalresearch.org/portal_work/testimony-reforming-the-340b-drug-pricing-program-and-ensuring-access-to-affordable-medications/ 2026-04-08T23:26:53+00:00 https://portalresearch.org/portal_work/identifying-drugs-for-state-pdab-affordability-review/ 2026-04-08T23:26:53+00:00 https://portalresearch.org/portal_work/conducting-drug-affordability-reviews-considerations-for-state-pdabs/ 2026-04-08T23:26:53+00:00 https://portalresearch.org/portal_work/identifying-therapeutic-alternatives-for-state-pdab-affordability-reviews/ 2026-04-08T23:26:53+00:00 https://portalresearch.org/portal_work/determining-upper-payment-limits-considerations-for-state-pdabs/ 2026-04-08T23:26:53+00:00 https://portalresearch.org/portal_work/health-technology-assessment-in-prescription-drug-coverage-and-pricing-decisions-examples-from-other-countries/ 2026-04-08T23:26:53+00:00 https://portalresearch.org/portal_work/prescription-drug-price-measures-to-inform-state-upper-payment-limits/ 2026-04-08T23:26:53+00:00 https://portalresearch.org/portal_work/testimony-in-support-of-h-866-an-act-relating-to-prescription-drug-manufacturer-cost-transparency/ 2026-04-08T23:26:53+00:00 https://portalresearch.org/portal_work/testimony-reauthorization-of-mdufa-what-it-means-for-jobs-innovation-and-patients/ 2026-04-08T23:53:20+00:00 https://portalresearch.org/portal_work/testimony-21st-century-cures-modernizing-clinical-trials/ 2026-04-08T23:53:20+00:00 https://portalresearch.org/portal_work/testimony-the-public-health-risks-of-expanding-off-label-promotion-of-prescription-drugs-and-devices/ 2026-04-08T23:53:20+00:00 https://portalresearch.org/portal_work/testimony-strategies-that-delay-timely-generic-entry-of-generic-drugs-and-potential-policy-solutions-the-creates-act-and-beyond/ 2026-04-08T23:53:20+00:00 https://portalresearch.org/portal_work/testimony-origins-of-and-solutions-to-high-drug-prices-in-the-us/ 2026-04-08T23:53:20+00:00 https://portalresearch.org/portal_work/testimony-high-us-prescription-drug-prices-anatomy-of-the-problem-and-prospects-for-reform/ 2026-04-08T23:53:20+00:00 https://portalresearch.org/portal_work/testimony-more-cures-for-more-patients-overcoming-barriers/ 2026-04-08T23:53:20+00:00 https://portalresearch.org/portal_work/testimony-drug-approval-during-the-covid-19-pandemic-following-the-evidence/ 2026-04-08T23:53:20+00:00 https://portalresearch.org/portal_work/testimony-congress-should-support-development-of-new-treatments-for-pediatric-rare-diseases-but-not-with-priority-review-vouchers/ 2026-04-08T23:53:20+00:00 https://portalresearch.org/portal_work/testimony-addressing-pharmaceutical-patent-abuses-could-lower-drug-spending-and-improve-patient-outcomes/ 2026-04-08T23:53:20+00:00 https://portalresearch.org/portal_work/testimony-how-the-us-government-supports-meaningful-drug-and-device-innovation-funding-development-of-transformative-therapies-and-avoiding-excessing-prices-for-new-products-with-limited-benefits/ 2026-04-08T23:53:20+00:00 https://portalresearch.org/portal_work/testimony-causes-of-unaffordable-prescription-drugs-monopolies-rebates-and-misaligned-incentives/ 2026-04-08T23:53:20+00:00 https://portalresearch.org/portal_work/testimony-the-inflation-reduction-act-of-2022-reducing-excessive-spending-and-support-patient-access-to-brand-name-drugs-while-promoting-meaningful-innovation/ 2026-04-08T23:53:20+00:00 https://portalresearch.org/portal_work/testimony-supporting-drug-innovation-and-fair-prices-for-patients-with-rare-diseases/ 2026-04-08T23:53:20+00:00 https://portalresearch.org/portal_work/testimony-nih-funding-drug-price-negotiation-and-biosimilars-three-factors-essential-for-patients-and-pharmaceutical-innovation/ 2026-04-08T23:53:20+00:00 https://portalresearch.org/portal_work/testimony-improving-residency-selection-and-addressing-threats-to-science-and-the-us-health-care-system/ 2026-04-08T23:53:20+00:00 https://portalresearch.org/portal_work/testimony-making-health-care-work-for-american-families-saving-money-saving-lives/ 2026-04-09T00:09:59+00:00 https://portalresearch.org/portal_work/comments-on-initial-guidance-for-the-medicare-drug-price-negotiation-program-ipay-2026/ 2026-04-09T00:36:10+00:00 https://portalresearch.org/portal_work/letter-on-s-3133-h-r-5497-the-conditional-approval-act/ 2026-04-09T00:36:10+00:00 https://portalresearch.org/portal_work/letter-to-louisiana-secretary-of-health-hepatitis-c-in-louisiana-recommendations-on-drug-availability/ 2026-04-09T00:36:10+00:00 https://portalresearch.org/portal_work/comments-on-draft-intellectual-property-consultative-framework/ 2026-04-09T00:36:10+00:00 https://portalresearch.org/portal_work/research-submission-to-inform-medicare-drug-price-negotiation-ipay-2027/ 2026-04-09T00:36:10+00:00 https://portalresearch.org/portal_work/comments-on-initial-guidance-for-the-medicare-drug-price-negotiation-program-ipay-2028/ 2026-04-09T00:36:10+00:00 https://portalresearch.org/portal_work/letter-on-s-2140-the-2024-patent-eligibility-restoration-act-pera/ 2026-04-09T00:36:10+00:00 https://portalresearch.org/portal_work/comments-on-draft-policy-nih-intramural-research-program-promoting-equity-through-access-planning/ 2026-04-09T00:36:10+00:00 https://portalresearch.org/portal_work/comments-on-discussion-draft-of-the-2023-modernizing-and-ensuring-pbm-accountability-act/ 2026-04-09T00:36:10+00:00 https://portalresearch.org/portal_work/comments-on-discussion-draft-of-2023-reauthorization-of-the-pandemic-and-all-hazards-preparedness-act/ 2026-04-09T00:36:10+00:00 https://portalresearch.org/portal_work/priority-without-progress-the-fdas-neglected-tropical-disease-voucher-program-after-18-years/ 2026-04-09T00:55:34+00:00 https://portalresearch.org/portal_work/assessing-outcomes-emerging-after-conversion-to-regular-approval-for-cancer-drug-indications-granted-accelerated-approval-1992-2021/ 2026-04-09T00:57:27+00:00 https://portalresearch.org/portal_work/testimony-should-fda-drug-and-medical-device-regulation-bar-state-liability-claims/ 2026-04-09T14:01:10+00:00 https://portalresearch.org/portal_work/brief-of-daniel-carpenter-aaron-kesselheim-jerry-avorn-marc-law-and-daniel-polsky-in-wyeth-v-levine/ 2026-04-09T18:47:35+00:00 https://portalresearch.org/portal_work/brief-of-health-law-policy-scholars-and-prescription-policy-choices-in-florida-v-hhs/ 2026-04-09T18:47:35+00:00 https://portalresearch.org/portal_work/brief-of-harvard-law-school-center-for-health-law-and-policy-innovation-et-al-in-gobeille-v-liberty-mutual/ 2026-04-09T18:47:35+00:00 https://portalresearch.org/portal_work/brief-of-constitutional-administrative-contracts-and-health-law-scholars-in-expressions-hair-design-v-schneiderman/ 2026-04-09T18:47:35+00:00 https://portalresearch.org/portal_work/brief-of-14-professors-of-medicine-and-law-in-teva-v-amneal/ 2026-04-09T18:47:35+00:00 https://portalresearch.org/portal_work/brief-of-14-professors-of-medicine-and-law-in-teva-v-amneal-rehearing-en-banc/ 2026-04-09T18:47:35+00:00 https://portalresearch.org/portal_work/brief-of-12-narcolepsy-patients-public-interest-organizations-medical-professionals-and-professors-of-law-and-medicine-in-jazz-v-avadel/ 2026-04-09T18:47:35+00:00 https://portalresearch.org/portal_work/brief-of-30-scholars-of-law-economics-and-medicine-in-hikma-v-amarin-cert-petition/ 2026-04-09T18:47:35+00:00 https://portalresearch.org/portal_work/brief-of-professors-of-law-medicine-and-public-health-in-vanda-v-united-states/ 2026-04-09T18:48:25+00:00 https://portalresearch.org/portal_work/brief-of-arnold-ventures-the-national-center-for-health-research-and-certain-medical-doctors-in-amgen-v-sanofi/ 2026-04-09T18:48:56+00:00 https://portalresearch.org/portal_work/using-behavioral-economics-to-promote-physicians-prescribing-of-generic-drugs-and-follow-on-biologics-what-are-the-issues/ 2026-04-09T19:43:55+00:00 https://portalresearch.org/portal_work/introduction-behavioral-economics-and-the-doctor-patient-relationship/ 2026-04-09T19:43:55+00:00 https://portalresearch.org/portal_work/brief-of-76-scholars-of-law-business-economics-and-medicine-in-hikma-v-amarin-merits/ 2026-04-11T17:23:27+00:00 https://portalresearch.org/portal_work/conflicts-of-interest-in-united-states-food-and-drug-administration-advisory-committees-a-systematic-literature-review/ 2026-04-11T17:26:04+00:00 https://portalresearch.org/portal_work/research-submission-to-inform-medicare-drug-price-negotiation-ipay-2028/ 2026-04-11T17:27:20+00:00 https://portalresearch.org/portal_work/brief-of-economists-and-scholars-of-health-policy-in-merck-v-becerra/ 2026-04-14T20:12:25+00:00 https://portalresearch.org/portal_work/brief-of-law-scholars-in-bms-v-becerra-and-janssen-v-becerra/ 2026-04-14T20:12:25+00:00 https://portalresearch.org/portal_work/brief-of-economists-and-scholars-of-health-policy-in-bms-v-becerra-and-janssen-v-becerra/ 2026-04-14T20:12:25+00:00 https://portalresearch.org/portal_work/brief-of-economists-and-scholars-of-health-policy-in-astrazeneca-v-becerra/ 2026-04-14T20:12:25+00:00 https://portalresearch.org/portal_work/brief-of-economists-and-scholars-of-health-policy-in-boehringer-ingelheim-v-becerra/ 2026-04-14T20:12:25+00:00 https://portalresearch.org/portal_work/brief-of-law-scholars-in-boehringer-ingelheim-v-becerra/ 2026-04-14T20:12:25+00:00 https://portalresearch.org/portal_work/brief-of-law-scholars-in-dayton-area-chamber-of-commerce-v-becerra/ 2026-04-14T20:12:25+00:00 https://portalresearch.org/portal_work/brief-of-law-scholars-in-novartis-v-becerra/ 2026-04-14T20:12:25+00:00 https://portalresearch.org/portal_work/brief-of-economists-and-scholars-of-health-policy-in-novo-nordisk-v-becerra/ 2026-04-14T20:12:25+00:00 https://portalresearch.org/portal_work/brief-of-law-scholars-in-novo-nordisk-v-becerra/ 2026-04-14T20:12:25+00:00 https://portalresearch.org/portal_work/brief-of-economists-and-scholars-of-health-policy-in-novartis-v-becerra/ 2026-04-14T20:12:25+00:00 https://portalresearch.org/portal_work/brief-of-economists-and-scholars-of-health-policy-in-national-infusion-center-association-v-kennedy/ 2026-04-14T20:12:25+00:00 https://portalresearch.org/portal_work/brief-of-economists-and-scholars-of-health-policy-in-teva-v-kennedy/ 2026-04-14T20:12:25+00:00 https://portalresearch.org/portal_work/price-changes-and-within-class-competition-of-cancer-drugs-in-the-usa-and-europe-a-comparative-analysis/ 2026-04-14T20:23:48+00:00 https://portalresearch.org/portal_work/out-of-pocket-spending-for-insulin-by-medicare-beneficiaries-after-monthly-caps/ 2026-04-15T13:52:02+00:00 https://portalresearch.org/portal_work/industry-payments-and-prescribing-of-brand-name-multiple-sclerosis-medications-in-medicare/ 2026-04-15T13:53:00+00:00 https://portalresearch.org/portal_work/brief-of-economists-and-scholars-of-health-policy-in-bms-v-kennedy-and-janssen-v-kennedy/ 2026-04-15T16:29:07+00:00 https://portalresearch.org/portal_work/brief-of-economists-and-scholars-of-health-policy-in-astrazeneca-v-kennedy/ 2026-04-15T16:29:07+00:00 https://portalresearch.org/portal_work/brief-of-law-scholars-in-novo-nordisk-v-kennedy/ 2026-04-15T16:29:07+00:00 https://portalresearch.org/portal_work/brief-of-economists-and-scholars-of-health-policy-in-national-infusion-center-association-v-kennedy-5th-circuit/ 2026-04-15T16:29:07+00:00 https://portalresearch.org/portal_work/brief-of-law-scholars-in-bms-v-kennedy-and-janssen-v-kennedy/ 2026-04-15T18:37:26+00:00 https://portalresearch.org/portal_work/brief-of-law-scholars-in-boehringer-ingelheim-v-kennedy/ 2026-04-15T18:40:22+00:00 https://portalresearch.org/portal_work/brief-of-law-scholars-in-novartis-v-kennedy/ 2026-04-15T18:41:56+00:00 https://portalresearch.org/portal_work/comments-on-proposed-rule-implementing-the-guarding-us-medicare-against-rising-drug-costs-guard-model/ 2026-04-22T16:12:19+00:00 https://portalresearch.org/portal_work/comments-on-proposed-rule-implementing-the-global-benchmark-for-efficient-drug-pricing-globe-model/ 2026-04-22T16:12:43+00:00 https://portalresearch.org/portal_work/testimony-public-funding-of-rd-and-fair-drug-prices-are-essential-to-support-innovation-in-biotechnology-2/ 2026-04-24T02:38:34+00:00 https://portalresearch.org/portal_work/transformative-models-to-promote-prescription-drug-innovation-and-access-a-landscape-analysis/ 2026-04-24T17:55:30+00:00 https://portalresearch.org/portal_work/views-from-academia-industry-regulatory-agencies-and-the-legal-system-2nd-ed/ 2026-04-24T17:56:09+00:00 https://portalresearch.org/portal_work/views-from-academia-industry-regulatory-agencies-and-the-legal-system-3rd-ed/ 2026-04-24T17:56:31+00:00 https://portalresearch.org/portal_work/pharmacoepidemiology-and-the-law/ 2026-04-24T17:56:52+00:00 https://portalresearch.org/portal_work/why-pharmaceutical-patent-thickets-are-unique/ 2026-04-24T17:58:12+00:00 https://portalresearch.org/portal_work/introduction-background-and-foundations/ 2026-04-24T19:32:21+00:00 https://portalresearch.org/portal_work/use-of-means-plus-function-claiming-to-evade-the-enablement-requirement/ 2026-04-24T19:32:53+00:00 https://portalresearch.org/portal_work/the-pharmaceutical-markets-adverse-effects/ 2026-04-24T19:35:33+00:00 https://portalresearch.org/portal_work/closing-the-evidence-gap-for-drugs-in-children-measures-to-strengthen-the-pediatric-research-equity-act/ 2026-04-27T14:41:55+00:00 https://portalresearch.org/portal_work/anticompetitive-mergers-pharmaceutical-buyouts-as-a-strategy-for-maintaining-market-dominance/ 2026-04-27T17:34:46+00:00 https://portalresearch.org/portal_work/skinny-labels-at-the-supreme-court-generic-competition-patent-inducement-and-affordable-medicines/ 2026-04-27T17:35:12+00:00